A new study has revealed more about how exposure to dim light in the evening affects circadian health. The findings emphasise the need to optimise our artificial light exposure if we are to avoid shifting our biological clocks.
Researchers are recommending public health interventions to reduce the long-term adverse outcomes associated with chronic insomnia and mental health problems.
Professor Robert MacLaren is the winner of the Inspiring Leadership category in the Vice-Chancellor's Innovation Awards 2020 for his work on Nightstar, a retinal gene therapy company.
An international group of researchers led by Professor Colin Espie is investigating the impact of the COVID-19 pandemic on sleep and daily rhythms in adults.
On the UNESCO International Day of Light, The Daylight Award announce the 2020 Laureates, including Russell Foster who receives the award for his clinical studies in humans addressing important questions regarding light.
NHS England has announced a programme to provide NHS staff with evidence-based digital programmes to protect their mental health during the COVID-19 response. The apps are designed to help maintain healthy sleep, and reduce anxiety.
A group of students got a taste of research at Oxford earlier this month when they spent a day analysing data at our Sleep and Circadian Neuroscience Institute.
The results of a first-in-human clinical trial of gene therapy to treat a common cause of genetic blindness have shown partial reversal of sight loss in some patients.
Researchers in Oxford have carried out the world\u2019s first gene therapy operation to tackle the root cause of age-related macular degeneration (AMD), the UK\u2019s most common cause of sight loss.
![\"\"](\"https://www.ndcn.ox.ac.uk/news/new-insights-into-the-effect-of-exposure-to-dim-light-in-the-evening-on-the-biology-of-the-sleep-wake-cycle/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n